Related Experiment Videos
Fast onset medications through thermally generated aerosols
Joshua D Rabinowitz1, Martin Wensley, Peter Lloyd
1Alexza Molecular Delivery Corporation, Palo Alto, CA 94303, USA. jrabinowitz@alexza.com
The Journal of Pharmacology and Experimental Therapeutics
|January 31, 2004
Summary
This study presents a new inhalation method for delivering pure pharmaceutical compounds without degradation products. This technique uses thermally generated aerosol for rapid systemic drug action, as shown with the antimigraine drug rizatriptan.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Aerosol Science
Background:
- Conventional smoking methods produce drug vapor with harmful degradation products.
- Inhalation of aerosols is a known route for systemic drug delivery.
- Thermal decomposition is a challenge in vaporizing pharmaceutical compounds.
Purpose of the Study:
- To develop a method for pure pharmaceutical compound delivery via inhalation.
- To prevent thermal degradation during drug vaporization.
- To achieve rapid systemic drug action through inhaled aerosols.
Main Methods:
- Coating pharmaceutical compounds as thin films on metallic substrates.
- Vaporizing the drug by heating the substrate.
- Rapid condensation and coagulation of vapor into aerosol particles.
- Inhalation of the generated drug aerosol.
Main Results:
- Successful delivery of pure pharmaceutical compounds without degradation products.
- Minimization of thermal exposure to prevent drug decomposition.
- Formation of micrometer-sized drug aerosol particles.
- Nearly instantaneous systemic action of rizatriptan upon inhalation.
Conclusions:
- This novel aerosol generation technique enables pure pharmaceutical delivery via inhalation.
- The method prevents thermal degradation, ensuring drug integrity.
- Rapid systemic drug action is achievable, offering a promising alternative for drug administration.